Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal English
Coverage 120,300 Raw stories ingested 13,325 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 50s ago
  • FMP Forex News Fetch every 5 min 3m ago
  • CoinGecko News Fetch every 5 min 3m ago
  • FIO Stock News Fetch every 10 min 2m ago
  • Patria Stock News Fetch every 10 min 2m ago
  • Editorial rewrite Rewrite every minute 50s ago
  • Asset sync Assets every 1 hour 42m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Clear
Details Date Content Source
2026-07-21 18:54 19d ago
2026-07-21 13:00 19d ago
Bank of America Enhances EricaAssist with Generative AI to Help Employees Resolve Client Needs Faster
BAC Bank of America
FMP Stock News
Original source text
Bank of America Enhances EricaAssist with Generative AI to Help Employees Resolve Client Needs Faster PR Newswire
2026-07-21 18:54 19d ago
2026-07-21 13:44 19d ago
Vanguard's VFH or Fidelity's FNCL: Which Financial ETF Is the Better Long-Term Buy?
JPM JPMorgan Chase
FMP Stock News
Original source text
Both funds track 400+ financial stocks with nearly identical sector weights. VFH offers a larger asset base and slightly higher yield, while FNCL charges a lower expense ratio.
2026-07-21 18:54 19d ago
2026-07-21 13:01 19d ago
All You Need to Know About Delta (DAL) Rating Upgrade to Buy
DAL Delta Airlines
FMP Stock News
Original source text
Delta Air Lines (DAL - Free Report) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.

Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.

As such, the Zacks rating upgrade for Delta is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.

Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.

For Delta, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.

Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.

The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .

Earnings Estimate Revisions for DeltaFor the fiscal year ending December 2026, this airline is expected to earn $6.66 per share, which is unchanged compared with the year-ago reported number.

Analysts have been steadily raising their estimates for Delta. Over the past three months, the Zacks Consensus Estimate for the company has increased 31%.

Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.

You can learn more about the Zacks Rank here >>>

The upgrade of Delta to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
2026-07-21 18:54 19d ago
2026-07-21 14:14 19d ago
ExxonMobil to Release Second Quarter 2026 Financial Results
XOM ExxonMobil
FMP Stock News
Original source text
SPRING, Texas--(BUSINESS WIRE)--ExxonMobil Holdings Corporation (NYSE: XOM) will release its second quarter 2026 financial results on Friday, July 31, 2026. The company will issue a press release via Business Wire that will be available at 5:30 a.m. CT at investor.exxonmobil.com. Darren Woods, Chairman and Chief Executive Officer; Neil Hansen, Senior Vice President and Chief Financial Officer; and Jim Chapman, Vice President, Corporate Finance and Treasurer, will review the results during a liv.
2026-07-21 18:53 19d ago
2026-07-21 12:30 19d ago
General Motors Rallies on Beat & Raise Quarter, Using GM Options Trade
GM General Motors
FMP Stock News
Original source text
Marley Kayden discusses General Motors' (GM) latest earnings as shares rally on a beat and raise quarter. She says consumer demand in North America remains strong even as tariffs and an unclear geopolitical backdrop pose last challenges.
2026-07-21 18:53 19d ago
2026-07-21 13:53 19d ago
General Motors Company (GM) Q2 2026 Earnings Call Transcript
GM General Motors
FMP Stock News
Original source text
General Motors Company (GM) Q2 2026 Earnings Call July 21, 2026 8:30 AM EDT

Company Participants

Ashish Kohli - Vice President of Investor Relations
Mary Barra - Chairman & CEO
Paul Jacobson - Executive VP & CFO

Conference Call Participants

Joseph Spak - UBS Investment Bank, Research Division
Dan Levy - Barclays Bank PLC, Research Division
Andrew Percoco - Morgan Stanley, Research Division
Itay Michaeli - TD Cowen, Research Division
Michael Ward - Citigroup Inc., Research Division
Emmanuel Rosner - Wolfe Research, LLC
Gautam Narayan - RBC Capital Markets, Research Division
Mark Delaney - Goldman Sachs Group, Inc., Research Division
Rajat Gupta - JPMorgan Chase & Co, Research Division

Presentation

Operator

Good morning, and welcome to the General Motors Company Second Quarter 2026 Earnings Conference Call.

[Operator Instructions] As a reminder, this conference call is being recorded, Tuesday, July 21, 2026. I would now like to turn the conference over to Ashish Kohli, GM's Vice President of Investor Relations.

Ashish Kohli
Vice President of Investor Relations

Thanks, Julie, and good morning, everyone. We appreciate you joining us as we review GM's financial results for the second quarter of 2026. Our conference call materials were issued this morning and are available on GM's Investor Relations website. We are also broadcasting this call via webcast.

Joining us today are Mary Barra, GM's Chair and CEO; along with Paul Jacobson, GM's Executive Vice President and CFO. Susan Sheffield, President and CEO of GM Financial, will also be joining us for the Q&A portion.

On today's call, management will make forward-looking statements about our expectations. These statements are subject to risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include the factors identified in our filings with the SEC. Please review the safe harbor statement on the first page of our presentation as the content of this call will be
2026-07-21 18:53 19d ago
2026-07-21 14:23 19d ago
Goldman Sachs creates private markets platform as rich investors seek the next SpaceX and Stripe
GS Goldman Sachs
FMP Stock News
Original source text
Goldman Sachs has created a new platform to expand its offerings for wealthy clients and family offices who increasingly want direct stakes in fast-growing private companies, CNBC has learned.

The new group, called the alternative investments platform, combines Goldman's existing alternatives business with two newly established teams, according to a memo seen first by CNBC.

The new teams focus on direct investments in individual private companies, rather than broader private equity funds, and on helping clients buy and sell those stakes, according to the memo.

"There has been a lot of focus on the big growth tech names and getting clients access to those before they debut in the public markets," Kristin Olson, Goldman Sachs' global head of alternatives for wealth, told CNBC in an interview.

Goldman's move reflects two of the biggest trends reshaping Wall Street. The firm has spent years pushing deeper into wealth and asset management because of its perception as providing steadier revenues than investment banking and trading. At the same time, the most successful startups are staying private far longer than they once did, allowing early investors to capture most of the gains before public investors get a chance.

"Companies are going public at a trillion dollars," Olson said. "If you haven't participated along the way, you're clearly missing a big part of the growth cycle."

AI boomGoldman has been arranging direct investments in later-stage private companies for wealthy clients for roughly two decades, Olson said, pointing to Facebook before its 2012 IPO and later SpaceX, Stripe and Canva. But growth in demand for the asset class convinced executives to break out the business, she added.

The firm's goal, Olson said, is to help clients identify promising companies before they become household names.

Rather than targeting early-stage startups, Olson said Goldman generally focuses on later-stage companies that have established products, meaningful revenue and clearer paths toward profitability, seeking what she described as a "sweet spot" between risk and return.

The AI investment boom has only intensified demand. Beyond leading model developers, Goldman is increasingly steering clients toward investments in the infrastructure underpinning AI, including data centers and related projects, Olson said.

watch now

The announcement comes days after Goldman reported record quarterly revenue, with executives highlighting AI-driven activity across investment banking, trading and financing businesses. The results reinforced investors' view that Goldman is positioned to benefit from multiple facets of the AI investment cycle.

The announcement also formalizes Goldman's growing business helping clients find liquidity for private investments.

Through its new secondary advisory group, the firm plans to expand a marketplace that allows clients to buy and sell private holdings while also advising clients looking to exit investments held outside Goldman.

"We said, let's break that out and let's make it very clearly defined as something that we're leaning into," Olson said.
2026-07-21 18:53 19d ago
2026-07-21 13:49 19d ago
Larry Fink Says AI Needs More Electricity. Google Is Trying To Need Less Of It.
BLK BlackRock
FMP Stock News
Original source text
Google’s reported next-generation AI chip, however, suggests there may be another way to attack the problem.

Google’s AI Bet Isn’t Just About Faster ChipsAccording to a CNBC report citing The Information, Google is developing an AI chip known internally as Frozen v2, designed to permanently embed parts of its Gemini AI model directly into the silicon.

Unlike conventional AI accelerators that rely primarily on software to run increasingly large models, Frozen v2 aims to integrate portions of the model into the hardware itself, improving inference efficiency while reducing the computing resources required to perform AI tasks.

The objective isn’t simply to make AI faster. It’s to make AI more efficient.

That distinction matters as hyperscalers race to build ever-larger AI infrastructure.

The AI Race May Become A Power RaceChina is currently building roughly 100 gigawatts of nuclear capacity and nearly 100 gigawatts of solar generation, investments Fink says are laying the foundation for the country’s AI ambitions. If electricity becomes the industry’s primary bottleneck, simply deploying more GPUs may no longer be enough.

That’s where Google’s reported chip strategy becomes particularly interesting.

Instead of solving the problem by generating more power, Google appears to be exploring how to accomplish more AI work with each watt of electricity consumed. If Frozen v2 delivers meaningful improvements in performance per watt, it could complement—not replace—the industry’s massive investments in data centers and power infrastructure.

Alphabet’s earnings will almost certainly focus on AI spending and cloud demand. But investors may want to listen for something else: whether the company is talking as much about AI efficiency as it is about AI scale.

If Fink is correct, the next contest in AI won’t simply be over who builds the biggest models—it will be over who can power them most efficiently.

Photo: Photo Agency/Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.
2026-07-21 18:52 19d ago
2026-07-21 13:11 19d ago
Will Hilton Worldwide (HLT) Beat Estimates Again in Its Next Earnings Report?
HLT Hilton
FMP Stock News
Original source text
Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Hilton Worldwide Holdings Inc. (HLT - Free Report) , which belongs to the Zacks Hotels and Motels industry.

This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 3.28%.

For the most recent quarter, Hilton Worldwide was expected to post earnings of $1.96 per share, but it reported $2.01 per share instead, representing a surprise of 2.55%. For the previous quarter, the consensus estimate was $2 per share, while it actually produced $2.08 per share, a surprise of 4.00%.

Price and EPS Surprise

For Hilton Worldwide, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with its solid Zacks Rank.

Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Hilton Worldwide has an Earnings ESP of +1.54% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #3 (Hold), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on July 28, 2026.

Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predictive power of this metric.

Many companies end up beating the consensus EPS estimate, though this is not the only reason why their shares gain. Additionally, some stocks may remain stable even if they end up missing the consensus estimate.

Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
2026-07-21 18:52 19d ago
2026-07-21 14:00 19d ago
Analyst Stays on Sidelines for PYPL Despite Stripe, Advent Buyout Offer
PYPL PayPal
FMP Stock News
Original source text
Even as Stripe and Advent seek to buy PayPal (PYPL) for a price that matches the company's current market cap, Owen Lau of Clear Street still has a hold rating for the stock. He discusses PayPal's strategic crossroads and how new leadership can affect the fintech firm.
2026-07-21 18:52 19d ago
2026-07-21 14:00 19d ago
Intel Q2 Preview: Time For The Turnaround To Deliver
INTC Intel
FMP Stock News
Original source text
I believe Intel Corporation CEO Tan is executing the turnaround quite well. Datacenter, ASICs, and 18A all look better, and the stock reflects that. That's precisely the problem. I now see a real INTC turnaround priced as though the hard part is already done. At 87x forward earnings, there is little room for error. Consensus for Q2 sits just above Intel's own guide. After seven straight revenue beats, simply landing near the midpoint is unlikely to be enough.
2026-07-21 18:51 19d ago
2026-07-21 13:01 19d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hertz Global Holdings - HTZ
HTZ Hertz
FMP Stock News
Original source text
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Hertz Global Holdings (“Hertz” or the “Company”) (NASDAQ: HTZ).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Hertz and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On June 24, 2026, Hertz issued a press release “announc[ing] that its wholly-owned indirect subsidiary, The Hertz Corporation (‘Hertz Corp.’), intends to offer, subject to market and other conditions, $300 million in aggregate principal amount of Exchangeable Senior First-Lien Secured PIK Notes due 2030 (the ‘Notes’) in a private offering to persons reasonably believed to be qualified institutional buyers[.]”  The press release specified that “Hertz Corp. intends to use the net proceeds received from the offering of the Notes for general corporate purposes, which may include the repayment of outstanding indebtedness.” 

On this news, Hertz’s stock price fell $2.06 per share, or 40.71%, to close at $3.00 per share on June 24, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980  
2026-07-21 18:51 19d ago
2026-07-21 13:35 19d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of International Business Machines Corporation - IBM
IBM IBM
FMP Stock News
Original source text
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of International Business Machines Corporation (“IBM” or the “Company”) (NYSE: IBM).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether IBM and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On July 14, 2026, IBM released its financial results for the second quarter of 2026.  IBM announced a disappointing quarter that it attributed to “a shortfall in our Z performance and the associated software stack, primarily in Transaction Processing.”  IBM also disclosed that it had “faltered,” and “did not adapt and move quickly enough” so that “numerous large deals failed to close on the timelines we expected, driving the majority of our shortfall.” 

On this news, IBM’s stock price fell $73.16 per share, or 25.21%, to close at $217.07 per share on July 14, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
2026-07-21 18:51 19d ago
2026-07-21 13:01 19d ago
All You Need to Know About UnitedHealth (UNH) Rating Upgrade to Strong Buy
UNH UnitedHealth Group
FMP Stock News
Original source text
UnitedHealth Group (UNH - Free Report) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.

The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.

Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.

As such, the Zacks rating upgrade for UnitedHealth is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.

Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. That's partly because of the influence of institutional investors that use earnings and earnings estimates for calculating the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their bulk investment action then leads to price movement for the stock.

Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for UnitedHealth imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.

Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.

The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .

Earnings Estimate Revisions for UnitedHealthFor the fiscal year ending December 2026, this largest U.S. health insurer is expected to earn $19.04 per share, which is unchanged compared with the year-ago reported number.

Analysts have been steadily raising their estimates for UnitedHealth. Over the past three months, the Zacks Consensus Estimate for the company has increased 7%.

Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.

You can learn more about the Zacks Rank here >>>

The upgrade of UnitedHealth to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
2026-07-21 18:50 19d ago
2026-07-21 13:15 19d ago
Goldman Sachs Says Oil Could Surpass $120 a Barrel if Hormuz Disruptions Don't Ease. Here's What That Means for Oil Stocks.
CVX Chevron
FMP Stock News
Original source text
Goldman Sachs sees a potential return of triple-digit crude prices on the horizon if disruptions to oil flows out of the Strait of Hormuz don’t ease soon. Analysts at the investment bank estimate that Brent crude oil, the global benchmark price, could top $120 a barrel next quarter and average more than $100 a barrel next year if that key waterway remains disrupted. The recent increase in hostilities between the U.S. and Iran has already driven Brent up over $90 a barrel, a roughly 30% surge from its recent bottom in the low $70s, when it appeared that the two sides had a deal to end hostilities and reopen the Strait.

Here’s a look at the investment bank’s current oil price scenarios and what they mean for oil stocks.

Image source: Getty Images.

Two paths for oil pricesAnalysts at Goldman Sachs recently published a note outlining their outlook for crude prices. The base case is that Brent will average $80 a barrel in the fourth quarter of 2026 and be around $75 next year. This outlook assumes that there’s a de-escalation in hostilities between the U.S. and Iran before the end of this year. Despite recent attacks by both sides, there’s renewed hope that they could take steps to de-escalate the current conflict. Several news outlets recently reported that mediators presented a proposal to Iran that included a 10-day ceasefire to revive peace talks between the countries.

However, while de-escalation is Goldman Sachs’ base case, it now sees upside price risks. Oil flows out of that key waterway have nearly stopped since the recent resurgence in fighting and have averaged 45% below pre-war levels in the last month, according to Goldman’s estimates. That’s driving the bank’s upside scenario. It sees Brent surging past $120 a barrel by the fourth quarter if the Strait remains disrupted. Meanwhile, it sees crude averaging $100 a barrel next year if the disturbance continues throughout 2027, and production in the Persian Gulf doesn’t recover to its pre-war level until the end of the year, when additional oil bypass pipeline capacity comes online.

Oil stocks can thrive in either scenarioGoldman Sachs’ upside scenario for oil prices would be a boon for oil producers. They’d cash in on triple-digit crude prices, enabling them to further strengthen their balance sheets and return more cash to shareholders through higher dividends and share repurchases. However, the bank’s base case for crude prices -- $80 by the fourth quarter and $75 a barrel in 2027 -- is still a great range for oil companies.

For example, Chevron (CVX +0.16%) can thrive at $70 oil. The company initially expected to generate an additional $12.5 billion in free cash flow this year at that oil price point, fueled by its merger with Hess, recently completed expansion projects, and cost-saving initiatives. Given where crude prices have been and Goldman Sachs’ estimates for the rest of this year, Chevron will vastly exceed that projection. Meanwhile, it can grow its free cash flow at a more than 10% annual rate through 2030 at $70 oil, putting it in a position for another strong showing in 2027.

Today's Change

(

0.16

%) $

0.31

Current Price

$

190.02

Fellow oil giant ExxonMobil (XOM +1.80%) can also thrive at lower oil prices. Exxon is in the middle of a multi-year structural cost-savings initiative that has already delivered $15.6 billion in cumulative savings since 2019, with the goal of reaching $20 billion by 2030. The oil giant is also investing heavily in its highest-return, highest-margin assets. These catalysts could add $25 billion in earnings growth and $35 billion in cash flow growth by 2030 at the same prices and margins as 2024. Exxon would produce $145 billion in surplus free cash during this period at $65 Brent. It’s on track to generate a lot more surplus cash over the next year at Goldman’s base case for oil prices.

Even the base case is optimistic for oil stocksGoldman Sachs sees the potential for crude prices to top $120 a barrel next quarter if the U.S. and Iran don’t de-escalate soon. That would enable oil companies like Exxon and Chevron to generate even bigger gushers of excess free cash flow. However, they’d still thrive under its base case. That makes oil stocks compelling investments in the current environment, as they should deliver strong returns in the base case and significant upside in a higher oil price scenario.
2026-07-21 18:49 19d ago
2026-07-21 12:30 19d ago
Salesforce Cratered 33% in 2026. One Analyst Sees It Exploding Nearly 200%
CRM Salesforce
FMP Stock News
Original source text
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Salesforce (NYSE:CRM | CRM Price Prediction) currently trades at $173.79, while the average Wall Street price target sits at $245.16. That is roughly a 41% implied upside gap.

Salesforce is the world’s largest customer relationship management software provider, repositioning itself around Agentforce, its platform for deploying autonomous AI agents inside enterprise sales, service, and marketing workflows. The AI monetization thesis is either real or it is not, and the 2026 selloff has forced the question.

Analysts have not backed off. Wedbush’s Dan Ives carries a $475 price target that implies roughly 173% upside from here.

A 34% Drawdown in a Rising Market CRM is down 34.05% year to date while the S&P 500 has gained 8.82%. That is violent underperformance for a mega-cap software name despite visibly improving fundamentals.

The catalyst was a slow-motion sector derating. IBM’s July warning about customers reallocating IT budgets toward AI infrastructure was described as a “hammer” slamming down on tech’s AI outsiders, with CRM named directly alongside ServiceNow. The fear is that enterprises are cutting seats on traditional application software to fund GPU spend, putting Salesforce squarely in the crosshairs.

The drawdown is strange given the earnings picture. Q1 FY27 delivered EPS of $3.88 against a $3.13 consensus, revenue of $11.13 billion up 13.3% YoY, and marked the fifth straight quarterly EPS beat. The market sold it anyway.

Why Ives and the Bulls Refuse to Blink The core bull thesis is that Agentforce represents a new subscription tier. Agentforce ARR hit $1.2 billion in Q1 FY27, up 205% YoY, and combined Agentforce plus Data 360 ARR reached roughly $3.4 billion, growing over 200% YoY.

Wedbush’s Dan Ives builds his $475 target on three pillars: Agentforce monetization as a structural upgrade cycle with fully autonomous agents driving high-margin ARR expansion; an unrivaled data moat through Data Cloud, where enterprises are forced to centralize customer data inside Salesforce to make agents functional; and margin expansion combined with re-accelerating growth, arguing the market underestimates how much AI upsell revenue will drop to free cash flow after cost discipline and the $25 billion accelerated buyback that shrank the share count.

Consensus ratings back the direction. Analysts split 6 Strong Buy, 34 Buy, 10 Hold, 0 Sell, and 2 Strong Sell. Management raised FY27 revenue guidance to $45.9 to $46.2 billion and set a $63 billion FY30 revenue target. Insider activity has skewed toward buying, with 55 recent insider transactions net positive. Analyst targets show reiterations and raises, not cuts.

The Software Group Got Hit, But CRM Fell Hardest Among the Cheap Names ServiceNow (NYSE:NOW) is down 31.65% YTD at $104.70, versus a $141.64 average target for roughly 35% upside. Wall Street is bullish (9 Strong Buy, 34 Buy, 4 Hold, 1 Sell), but the multiple stays rich and the AI-capex-crowding-out story hangs over next quarter’s earnings report.

Oracle (NYSE:ORCL) is the outlier. Shares sit at $121.38, down 37.12% YTD, against a $251.85 target implying more than 107% upside. Ratings tilt heavily bullish (8 Strong Buy, 29 Buy, 5 Hold, 1 Sell), but AI-driven capex has turned free cash flow deeply negative.

HubSpot (NYSE:HUBS) trades at $231.26, off 42.38% YTD, with a $275.72 target and modest 19% upside. Recent revisions have skewed negative, including a Wells Fargo downgrade to Equal Weight with a cut from $300 to $225.

The largest analyst-implied upside in this group sits with Oracle on consensus, but CRM’s $475 high-water target is the boldest single call. This is a group derating, and Salesforce has the widest range between consensus and the most bullish voice.

What the Stock Actually Says About Salesforce CRM sits at $173.79 with a consensus target of $245.16, an implied upside of roughly 41%, drawn from a coverage universe of 52 analysts. Trailing P/E is 20x and forward P/E is 13x, unusually cheap for a name growing revenue in the low double digits with 77% gross margins.

Year to date the stock is down 34.05% against the S&P 500’s gain of 8.82%. Over the last month, CRM has clawed back 14.5% while the index slipped 0.62%, hinting that capitulation may be finished.

Where I Land on Salesforce at $173 The bull case works if you believe Agentforce is a real product cycle rather than a marketing wrapper. The fundamentals support that read: five straight EPS beats, ARR compounding at triple digits, buybacks shrinking the float, and a forward P/E in the low teens. The path back to $245 is Agentforce ARR crossing $2 billion, current RPO growth staying in the mid-teens, and one clean quarter that puts the IBM-warning fears to bed.

The bear case works if you think the IBM thesis is correct and enterprises are reallocating software budgets toward GPUs and hyperscaler consumption. In that world, seat-based CRM revenue stalls, Agentforce cannibalizes rather than expands, and the $39.3 billion in noncurrent debt from the buyback becomes a real drag on multiple.

My lean is cautiously long. Ives’ $475 target is aggressive, but consensus at $245 looks reachable inside 12 months if management delivers promised H2 FY27 acceleration. The risk/reward at 13x forward earnings with 200%+ ARR growth in the AI segment is asymmetric enough to matter.

Contact [email protected] for any questions or corrections.
2026-07-21 18:49 19d ago
2026-07-21 12:41 19d ago
CRM vs. ADYEY: Which Stock Should Value Investors Buy Now?
CRM Salesforce
FMP Stock News
Original source text
Investors looking for stocks in the Internet - Software sector might want to consider either Salesforce (CRM - Free Report) or Adyen N.V. Unsponsored ADR (ADYEY - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.

Right now, Salesforce is sporting a Zacks Rank of #2 (Buy), while Adyen N.V. Unsponsored ADR has a Zacks Rank of #3 (Hold). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that CRM has an improving earnings outlook. But this is just one factor that value investors are interested in.

Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.

Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.

CRM currently has a forward P/E ratio of 12.31, while ADYEY has a forward P/E of 20.82. We also note that CRM has a PEG ratio of 0.68. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. ADYEY currently has a PEG ratio of 1.25.

Another notable valuation metric for CRM is its P/B ratio of 4.16. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities. By comparison, ADYEY has a P/B of 5.48.

These metrics, and several others, help CRM earn a Value grade of B, while ADYEY has been given a Value grade of D.

CRM sticks out from ADYEY in both our Zacks Rank and Style Scores models, so value investors will likely feel that CRM is the better option right now.
2026-07-21 18:49 19d ago
2026-07-21 14:33 19d ago
Genuine Parts Company (GPC) Q2 2026 Earnings Call Transcript
GPC Genuine Parts Company
FMP Stock News
Original source text
Genuine Parts Company (GPC) Q2 2026 Earnings Call July 21, 2026 8:30 AM EDT

Company Participants

Timothy Walsh - Vice President of Investor Relations
William Stengel - CEO & Chairman
Herbert Nappier - Executive VP & CFO

Conference Call Participants

Gregory Melich - Evercore ISI Institutional Equities, Research Division
Christopher Horvers - JPMorgan Chase & Co, Research Division
Scot Ciccarelli - Truist Securities, Inc., Research Division
Michael Lasser - UBS Investment Bank, Research Division
Bret Jordan - Jefferies LLC, Research Division

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to the Genuine Parts Company Second Quarter 2026 Earnings Conference Call. [Operator Instructions] This call is being recorded on Tuesday, July 21, 2026.

I would now like to turn the conference over to Tim Walsh. Please go ahead.

Timothy Walsh
Vice President of Investor Relations

Thank you, and good morning, everyone. Welcome to Genuine Parts Company's Second Quarter 2026 Earnings Call. Joining us on the call today are Will Stengel, Chairman and Chief Executive Officer; and Bert Nappier, Executive Vice President and Chief Financial Officer. In addition to this morning's press release, a supplemental slide presentation can be found on the Investors page of the Genuine Parts Company website. Today's call is being webcast, and a replay will also be made available on the company's website after the call.

Following our prepared remarks, the call will be open for questions, the responses to which will reflect management's views as of today, July 21, 2026. If we're unable to get to your questions, please contact our Investor Relations department. Please be advised that this call may include certain non-GAAP financial measures, which may be referred to during today's discussion of our results as reported under generally accepted accounting principles. A reconciliation of these measures is provided in the earnings press release. Today's call may also include forward-looking statements regarding the company and its businesses as
2026-07-21 18:49 19d ago
2026-07-21 13:01 19d ago
Commerce (CBSH) Moves to Buy: Rationale Behind the Upgrade
CBSH Commerce Bancshares
FMP Stock News
Original source text
Investors might want to bet on Commerce Bancshares (CBSH - Free Report) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.

Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.

Therefore, the Zacks rating upgrade for Commerce basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.

Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.

Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Commerce imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.

Harnessing the Power of Earnings Estimate RevisionsEmpirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, so it could be truly rewarding if such revisions are tracked for making an investment decision. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.

The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .

Earnings Estimate Revisions for CommerceFor the fiscal year ending December 2026, this bank holding company is expected to earn $4.22 per share, which is unchanged compared with the year-ago reported number.

Analysts have been steadily raising their estimates for Commerce. Over the past three months, the Zacks Consensus Estimate for the company has increased 4.1%.

Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.

You can learn more about the Zacks Rank here >>>

The upgrade of Commerce to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
2026-07-21 18:46 19d ago
2026-07-21 13:16 19d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Hyliion Holdings Corp. - HYLN
HYLN Hyliion
FMP Stock News
Original source text
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Hyliion Holdings Corp. (“Hyliion” or the “Company”) (NYSE: HYLN).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Hyliion and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On June 23, 2026, Pelican Way Research (“PWR”) published a short report entitled “Hyliion: A Glorified Science Project Who Has Continuously Failed To Meet Expectations And Is Now Throwing Around A Meaningless Deal.”  The report stated that Hyliion’s stock had risen significantly following the Company’s announcement of a non-binding letter of intent (“LOI”) with VFG Holdings (“VFG”) for up to 250 KARNO Cores, representing approximately $133 million in potential revenue.  The PWR report alleged that the VFG LOI accounted for roughly one-third of Hyliion’s reported $400 million-plus pipeline and questioned whether the LOI provided meaningful commercial validation. The report further alleged that VFG, which PWR identified as VFG Tech Holdings, LLC, was incorporated in January 2026, appeared to have only four employees listed on LinkedIn, had only a minimal website, and lacked evidence of funding or operating substance sufficient to support an order of that size. 

Following publication of the PWR report, Hyliion’s stock price fell $1.27 per share, or 17.2%, to close at $6.10 per share on June 23, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
2026-07-21 18:46 19d ago
2026-07-21 11:33 19d ago
If a Stock Market Crash Comes in July, You'll Still Rest Easy Knowing You Bought This Dividend Stock
COST Costco Wholesale
FMP Stock News
Original source text
All the fears that worried the market in the past are percolating. Inflationary concerns are rising, with oil prices near a six-week high, more tariffs, and geopolitical tensions in the Middle East unlikely to go away anytime soon. The Federal Reserve is likely to nudge rates higher -- not lower -- the next time it meets. Suddenly, everything that is borrowed is about to be something blue.

It's against this unsettling climate, with consumer confidence hitting a new low before rebounding this summer, that investors might want to consider investing in Costco (COST 0.63%). Yes, Costco.

The country's top warehouse club operator may not seem much of a growth stock. It's also certainly not cheap by most measuring sticks. However, if reality catches up to today's buoyant market later this month, you're probably going to learn the real reason why Costco is worth its market premium.

Image source: Getty Images.

Welcome to Costco, I love you Costco stock is trading for 47 times trailing earnings, a big markup to both the market average and the retailer's own growth. Its revenue multiple may initially seem low at 1.4, but in the low-margin world of groceries and other consumer staples retail, it's a princely premium. If you're an income investor, the stock's 0.6% dividend yield isn't going to ring a dinner bell, even though Costco does reward shareholders with substantially larger special dividends every few years.

The warehouse club operator's appeal in bear markets, if not outright crashes, lies in its resilience. Costco has posted positive net sales growth in 32 of the last 33 years. The one time it fell short was a modest 1.5% decline in 2009 during the Great Recession. It was a stalwart that year, as the U.S. corporate sector saw its revenue plummet 13%.

Today's Change

(

-0.63

%) $

-5.86

Current Price

$

929.94

You beta, you beta, you bet Costco's beta -- a measure of stock volatility -- clocks in at 0.87, only slightly below the market at 1.00. However, the all-weather retailer's one-year beta is roughly zero. Put another way, over the past year, Costco shares haven't moved in step with the market. If you're worried about a market crash, this lack of correlation should excite you.

In a rising market, Costco investors have experienced a 2% decline. This may not seem bullish, but with Costco's business continuing to expand and its dominance growing, its valuation has become even more compelling than a year ago.

Costco isn't cheap, but it's a safe, recession-resistant stock, if not recession-resilient. You don't typically say that about a company with a paid membership model, but the money it collects from its 82.9 million paid memberships accounts for most of its profit. Shoppers know they are getting a good deal, and that matters even more when the economy is headed in the wrong direction.

Nobody wants the market to crash, but it will inevitably happen several times in your lifespan as an investor. It's good to have Costco on your side, ready for the worst, like an airbag in a car or a flotation device on a boat or a plane.
2026-07-21 18:46 19d ago
2026-07-21 14:14 19d ago
Prediction: Costco Will Join the $1 Trillion Club by 2033
COST Costco Wholesale
FMP Stock News
Original source text
Here is a prediction I feel good about: Costco Wholesale (COST 0.63%) will join the $1 trillion club by 2033. The warehouse retailer is worth roughly $417 billion today, so to reach a 13-figure market cap, it will need to grow by just about 140%. That may sound ambitious for a company that sells rotisserie chickens and bulk packages of paper towels, but Costco has one of the most reliable growth machines in all of retail, and the math is more achievable than you might think.

The secret to Costco is that it barely makes a profit at the register from selling groceries and household goods. It makes its profits from selling memberships. The company now counts more than 40 million paid household memberships, with over 82 million cardholders in total, and a renewal rate above 92%, meaning almost everyone who joins stays. Membership fee income, which is nearly pure profit, keeps climbing, helped by a recent fee increase. That sticky recurring revenue is the closest thing retail has to a subscription business, and it is remarkably durable in any type of economy.

Image source: Getty Images.

Costco has plenty of room left to grow Costco is also far from finished with its expansion. It is opening new warehouses at a pace of more than 30 a year, backed by billions of dollars in annual investments, and management has laid out a five-to-10-year roadmap for continued growth across the U.S. and abroad.

Its e-commerce sales have climbed more than 20%, with artificial-intelligence-driven product recommendations lifting online spending. For a company this large to still be growing its store base and digital sales at a clip that healthy is exactly what it will take for it to reach a $1 trillion market cap.

Today's Change

(

-0.63

%) $

-5.86

Current Price

$

929.94

Why I could be wrong I will be honest about the risks here. Costco already trades at a rich valuation, well above that of a typical retailer, so a big chunk of its expected future success is arguably already priced into the stock. If that premium multiple compresses, the stock could grow more slowly than the business does, and the point at which it could pass the trillion-dollar milestone would slip further into the future.

Intensifying competition or economic weakness for consumers could also cool its growth pace. 

However, whether Costco crosses the $1 trillion mark in 2033 or a year or two later, the deeper point stands. This is one of the steadiest compounding machines in the market, powered by loyal members who happily pay to shop in its stores. I think that combination of dependable membership profits and a long runway of new warehouses will get it into the trillion-dollar club within the next several years. Own it for the compounding, not the exact date, and let one of retail's best business models do the heavy lifting.
2026-07-21 18:46 19d ago
2026-07-21 12:31 19d ago
T1 Energy vs. First Solar: Which Solar Stock Has More Upside?
FSLR First Solar
FMP Stock News
Original source text
Key Takeaways T1 Energy is expanding solar manufacturing and entering battery storage through the KORE Power acquisition.First Solar is increasing module capacity while its order backlog extends through 2030.Both companies are positioned to benefit from rising U.S. solar demand and domestic manufacturing expansion. T1 Energy (TE - Free Report) and First Solar (FSLR - Free Report) provide investors with exposure to the growing U.S. solar industry. T1 Energy is an emerging clean energy manufacturer that is in the early stages of building its solar business, while First Solar is the largest and most established solar manufacturer in the United States. Both companies stand to benefit as governments continue to promote domestic clean energy production and supply-chain localization.

The comparison is particularly relevant today because both companies are positioned to benefit from the same long-term industry tailwinds. The U.S. government's emphasis on strengthening domestic solar manufacturing, reducing dependence on imported panels, and expanding renewable energy capacity has created a favorable environment for American solar manufacturers. Companies that can successfully scale domestic production while maintaining competitive costs are likely to benefit from increasing demand over the coming years.

Let us compare the stocks' fundamentals to determine which one is a better investment option at present.

Factors Acting in Favor of TE StockT1 Energy already operates one of the world's largest and most advanced solar module manufacturing facilities while building a 2.1 gigawatt (GW) solar cell plant that will significantly expand its domestic production capacity. Management has indicated that customer demand for the combined output of these facilities already exceeds planned production for 2027 and 2028, suggesting strong market demand, high expected utilization, and improved revenue visibility. Beyond solar manufacturing, the company is expanding into battery energy storage systems (BESS) and energy infrastructure solutions for high-growth markets, such as hyperscale data centers. This diversification broadens its revenue opportunities and positions it to capitalize on multiple long-term energy transition trends.

In June 2026, T1 Energy entered into a definitive agreement to acquire KORE Power, Inc., an established engineering-focused BESS and software solutions provider supporting industrial hyperscaler development. Through this acquisition, the company is expected to gain an established engineering platform with decades of experience in designing, deploying and operating utility-scale battery storage systems, along with deep relationships with utilities, government agencies, developers and industrial customers.

Factors Acting in Favor of FSLR StockFirst Solar has been investing heftily in the production ramp-up of its modules to expand its manufacturing capacity. The company manufactured 4.3 GW in the first quarter of 2026 and sold 3.8 GW of solar modules. With a strong global footprint, First Solar enjoys a solid presence in the United States, India, Malaysia and Vietnam. The company’s new 3.7 GW capacity module finishing line in the United States is expected to commence operations in the fourth quarter of 2026. These vigorous manufacturing capacity expansions will help boost its revenues.

The growth prospects of FSLR remain solid in the United States, thanks to favorable solar demand growth in the nation. The company commenced operations at its fourth and fifth manufacturing facilities in the United States and completed the expansion of its manufacturing footprint at its existing facilities in Ohio. FSLR has added 1.9 GW of gross booking since the previous earnings call and its total booking backlog is 47.9 GW extending through 2030, which indicates a strong demand for its products.

How Do Zacks Estimates Compare for TE & FSLR?The Zacks Consensus Estimate for T1 Energy’s 2026 earnings per share (EPS) indicates growth of 85.28% year over year. 
 

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for First Solar’s 2026 EPS implies growth of 23.43%.

Image Source: Zacks Investment Research

Valuation for TE & FSLRT1 Energy’s shares trade at a forward 12-month price/sales (P/S F12M) of 1.56X compared with First Solar’s P/S F12M of 3.91X.

Image Source: Zacks Investment Research

TE & FSLR Stock’s LiquidityCurrent ratio for TE and FSLR is 1.26 and 2.56, respectively. A ratio of more than one suggests a healthy liquidity position, in which the business can meet its immediate financial obligations without selling long-term assets.

TE & FSLR Stock’s Price PerformanceIn the past three months, shares of T1 Energy and First Solar have risen 18.3% and 10.1%, respectively, compared with the industry’s 4.7% growth.

Image Source: Zacks Investment Research

TE & FSLR: Which Is a Better Choice Now?Expanding manufacturing capacity, strong customer demand, and diversification into battery storage and energy infrastructure position T1 Energy for sustained long-term growth. Ongoing manufacturing expansion, a strong order backlog, and favorable solar demand trends position First Solar for continued revenue growth.

Our choice at the moment is T1 Energy, given its better earnings growth, price performance, and more attractive valuation than First Solar. Both TE and FSLR carry a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
2026-07-21 18:46 19d ago
2026-07-21 12:52 19d ago
Pomerantz Law Firm Announces the Filing of a Class Action Against First Solar, Inc. and Certain Officers – FSLR
FSLR First Solar
FMP Stock News
Original source text
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against First Solar, Inc. (“First Solar” or the “Company”) (NASDAQ: FSLR) and certain officers. The class action, filed in the United States District Court for the Eastern District of New York, and docketed under 26-cv-03787, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired First Solar securities between February 26, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are an investor who purchased or otherwise acquired First Solar securities during the Class Period, you have until August 24, 2026, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.  
 

[Click here for information about joining the class action]

First Solar is a solar technology company that provides photovoltaic (“PV”) solar energy solutions. First Solar manufactures and sells PV solar modules that convert sunlight into electricity. As relevant here, First Solar’s product offerings include its Series 6 Plus PV module, manufactured at facilities in locations including Malaysia and Vietnam.

At the outset of the Class Period, Defendants announced that First Solar would reduce production output of Series 6 modules at facilities in Malaysia and Vietnam in 2025, to account for circumstances including, inter alia, an “uncertain U.S. policy environment following the 2024 U.S. elections,” and “a supply and demand imbalance for Southeast Asian product”. Notwithstanding these circumstances, First Solar reassured investors that its primary market, the United States, enjoyed stable module prices.

Then, on April 2, 2025, United States (“U.S.”) President Donald J. Trump announced a series of “reciprocal” tariffs on U.S. imports from all countries, including rates of 24% and 46% on Malaysia and Vietnam, respectively, presenting a challenge to First Solar. These tariffs were subsequently reduced to 10%. Throughout the Class Period, Defendants continued to assure investors that the dynamic policy landscape presented a “long term favorable” for First Solar and actually “strengthened [its] relative position in the solar manufacturing industry”.

The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Defendants had overstated First Solar’s capacity to manage the impact of U.S. tariff policy on the Company’s business; (ii) Defendants understated the extent to which its responses to U.S. tariff policy, including the intentional underutilization of production facilities in Malaysia and Vietnam, and attempted relocation of production to the U.S., were likely to negatively impact First Solar’s projected performance in the 2026 fiscal year; and (iii) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

The truth began to emerge on January 7, 2026, when Jefferies downgraded First Solar to Hold from Buy, noting that during 2025, the Company had lowered guidance, faced significant de-bookings and experienced margin compression through 2025. Jefferies also flagged that “[international] facilities remain a pain point while tariffs exist” and “underutilization at [international] facilities remains a concern.” The Jefferies analyst also predicted that First Solar’s deployment opportunities were likely to be more limited in 2026.

On this news, First Solar’s stock price fell $27.67 per share, or 10.29%, to close at $241.11 per share on January 7, 2026.

Then, on February 24, 2026, First Solar issued a press release “announc[ing] financial results for the fourth quarter and year ended December 31, 2025.” Among other items, First Solar announced earnings that missed expectations by a wide margin and issued lower-than-expected FY 2026 revenue guidance, citing customer headwinds such as permitting delays under the Trump administration. Following First Solar’s announcement, Baird Research downgraded its stock to Neutral from Outperform, citing “several question marks in forward outlook”.

On this news, First Solar’s stock price fell $33.09 per share, or 13.61%, to close at $210.12 per share on February 25, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com. 

Attorney advertising.  Prior results do not guarantee similar outcomes.    

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
2026-07-21 18:46 19d ago
2026-07-21 13:00 19d ago
First Solar, Inc. (FSLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
FSLR First Solar
FMP Stock News
Original source text
First Solar, Inc. (FSLR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire
2026-07-21 18:46 19d ago
2026-07-21 13:27 19d ago
Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials
GILD Gilead Sciences
FMP Stock News
Original source text
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo Purchase Licensing Rights, opens new tab

CompaniesJuly 21 (Reuters) - Gilead Sciences (GILD.O), opens new tab and Merck (MRK.N), opens new tab said on Tuesday their experimental once-weekly HIV pill kept the virus suppressed in two late-stage trials, ​supporting regulatory filings for what could become the first ‌regimen of its kind for the disease.

Here are some details:

Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.

The combination of Merck's islatravir and Gilead's lenacapavir was tested as a single-tablet regimen in adults ​whose HIV was already controlled with daily antiretroviral therapy.

HIV ​attacks the body's immune system and, if left untreated, ⁠can progress to acquired immunodeficiency syndrome (AIDS), the most advanced stage of ​infection.

In one trial, none of the patients who switched to the ​weekly pill had detectable viral levels at 48 weeks, compared with 0.3% of those who remained on Gilead's daily Biktarvy.

In a second trial, 0.3% of ​patients taking the weekly pill had detectable HIV levels or ​higher at 48 weeks, compared with 1.3% of those who remained on standard ‌daily ⁠HIV regimens.

Investors are closely watching the rollout of lenacapavir, branded as Yeztugo, which was approved last year, as Gilead seeks to strengthen its HIV franchise alongside blockbuster treatment Biktarvy.

The companies said the weekly ​treatment was non-inferior ​to Biktarvy ⁠and other daily HIV regimens in the two studies, meaning it performed at least as well by ​the studies' main measure.

Side effects were generally similar ​to ⁠the daily treatments studied, and no new safety concerns were identified. The most common treatment-related side effects included headache, nausea and diarrhea.

Merck's once-daily ⁠HIV ​pill combo Idvynso was approved by the U.S. ​Food and Drug Administration in April, bringing another treatment option for patients suffering from ​the condition.

Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Vijay Kishore

Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-07-21 18:46 19d ago
2026-07-21 12:18 19d ago
Realty Income: The Bull Case Relies More On Valuation Than Earnings
O Realty Income
FMP Stock News
Original source text
Realty Income is rated Hold as current prices embed strong long-term growth not fully supported by recent numbers. Q1 2026 AFFO growth was driven mostly by non-recurring items, with core organic rental growth modest and same-store rents lagging inflation. The dividend remains well-covered with a 72% payout ratio and strong occupancy, but dividend growth is slowing and yield has compressed below 5%.
2026-07-21 18:45 19d ago
2026-07-21 12:46 19d ago
Portfolio Diversification and Premiumization Fuel Molson Coors' Outlook
TAP Molson Coors Brewing
FMP Stock News
Original source text
Key Takeaways Molson Coors is pursuing Horizon 2030 to strengthen core brands and expand beyond beer categories.TAP is benefiting from momentum in premium brands like Peroni, Blue Moon and Coors Banquet.Acquisitions, cost savings and marketing investments are supporting Molson Coors' growth strategy. Molson Coors Beverage Company (TAP - Free Report) is executing a long-term growth strategy that emphasizes strengthening its core beer portfolio while expanding into higher-growth beverage categories. Building on its “Acceleration Plan” and the recently launched “Horizon 2030” strategy, the company is working to evolve from a traditional brewing business into a diversified beverage company.

Premiumization remains a key component of Molson Coors’ growth strategy as it expands its portfolio of higher-margin products, including premium beers and flavored alcoholic beverages. The company is benefiting from the strong performance of its premium brands and leveraging strategic pricing actions and a favorable product mix to support revenue growth despite ongoing volume pressures.

The company is seeing strength in above-premium offerings such as Peroni, Blue Moon, Coors Banquet and Madri Excepcional, which are expected to play an increasingly important role in driving sales and profitability. Molson Coors continues to support value-oriented brands, including Miller High Life and Keystone, through targeted innovation initiatives and localized market execution.

Molson Coors’ Horizon 2030 strategy is expected to support sustainable top-line growth. The strategy centers on strengthening the company’s core brands, expanding its presence in the above-premium beer segment and accelerating growth in faster-growing beyond-beer categories. Molson Coors continues to invest in its commercial capabilities, technology and marketing initiatives while leveraging acquisitions, such as Fever-Tree and Monaco Cocktails, to diversify its portfolio and unlock new growth opportunities.

TAP’s cost savings to support long-term value creation appear encouraging. Such endeavors will position Molson Coors to capitalize on evolving consumer preferences, strengthen its competitive position and support sustainable long-term revenue and earnings growth.

TAP’s Price Performance, Valuation and EstimatesShares of Molson Coors have lost 16.4% in the past six months compared with the industry’s rise of 4.7%.

Image Source: Zacks Investment Research

From a valuation standpoint, TAP trades at a forward price-to-earnings ratio of 8.48X compared with the industry’s average of 15.32X.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for TAP’s 2026 earnings per share (EPS) shows a decline of 11.4% while that of 2027 indicates year-over-year growth of 4.2%. The company’s EPS estimate for 2026 and 2027 has been stable in the past 30 days.

Image Source: Zacks Investment Research

Molson Coors stock currently carries a Zacks Rank #3 (Hold).

Stocks to Consider in the Consumer Staples Space  United Natural Foods (UNFI - Free Report) , which is the leading distributor of natural, organic and specialty food and non-food products, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

 The Zacks Consensus Estimate for United Natural Foods’ current financial-year sales indicates a drop of 2.1% from the prior-year level. UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.

 Medifast, Inc. (MED - Free Report) , which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank #2 (Buy). MED missed the average earnings surprise by a sharp margin in the trailing four quarters.

 The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates a decline of 25.9% from the year-ago number.

 Freshpet, Inc. (FRPT - Free Report) , which manufactures and markets natural fresh foods, refrigerated meals, and treats for dogs and cats, currently carries a Zacks Rank of 2.

 The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 9.5% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 49.4%, on average.
2026-07-21 18:45 19d ago
2026-07-21 12:44 19d ago
Kraft Heinz Bets on Disney to Revive Its Brands
KHC Kraft Heinz
FMP Stock News
Original source text
Kraft Heinz's multiyear partnership with Disney expands its brands across theme parks, cruises, streaming, and consumer products, but investors see little reason to change earnings expectations without evidence the deal will boost growth.
2026-07-21 18:44 19d ago
2026-07-21 13:00 19d ago
Palantir Stock Is Down More Than 35% from Its Peak. Is It Finally a Buy?
PLTR Palantir Technologies
FMP Stock News
Original source text
Just a few months ago, investors couldn't get enough of Palantir Technologies (PLTR 1.57%). The company -- known for "big data" analytics -- was delivering record earnings, demand for its artificial intelligence (AI) software was surging, and the stock seemed unstoppable.

Fast-forward to today, and the mood has changed. Although the business continues to execute at a high level, Palantir's stock has fallen roughly a third from its peak. That naturally raises an important question.

Has this correction finally created a buying opportunity, or is the stock still too expensive?

Image source: Getty Images.

The business hasn't been the problem Most investors who focus only on Palantir's operating results will probably struggle to explain why the stock corrected so sharply. The company recently reported another outstanding quarter. Revenue for the period grew 85% year over year to $1.6 billion, while U.S. commercial revenue grew more than 130%, highlighting strong demand from businesses adopting its Artificial Intelligence Platform (AIP).

The quality of that growth is just as impressive. Unlike many fast-growing AI companies, Palantir is generating meaningful profits and strong free cash flow. Management has also continued to raise its revenue guidance, suggesting that demand remains healthy. In other words, the business is performing well. If anything, Palantir's business is stronger today than it was when the stock was making new highs.

Then why did the stock fall? Here's where many investors get confused. They assume a falling stock price means a weakening business. Sometimes that's true. But sometimes the business keeps improving while the stock falls. That's largely what happened with Palantir.

During the early AI boom, investors were willing to pay an extraordinary premium for companies they believed would dominate the next generation of enterprise software. Palantir was one of those companies. Eventually, however, Wall Street stopped asking one question: "Is Palantir a great company?" Instead, it started asking another: "How much is a great company worth?"

That shift in focus changed everything. Once expectations become exceptionally high, even excellent earnings may not be enough to push the stock higher. Investors simply become less willing to pay an unlimited premium for future growth.

Today's Change

(

-1.57

%) $

-2.12

Current Price

$

132.73

Has the correction made Palantir cheap? The recent pullback has undoubtedly made Palantir more attractive than it was at its peak. Investors today are paying less for the same business. That's a positive.

But that doesn't automatically make the stock cheap. Even after the correction, Palantir still trades at a huge premium multiple -- its price-to-earnings (P/E) ratio stood at 167 as of this writing -- which is significantly higher than many of the market's other AI leaders. For instance, Nvidia trades at a P/E of around 37. 

But here's the thing: A high P/E ratio doesn't necessarily mean Palantir is overvalued. It simply means investors expect Palantir to expand at hypergrowth rates over the next several years. They're paying today for profits they believe the company will generate tomorrow.

Having said that, it does mean the margin for error remains thin. If Palantir continues executing at an exceptional level, today's valuation could look reasonable. But if growth slows, investors may look back and regret paying up for the stock today.

What does it mean for investors? Palantir remains one of the most compelling enterprise AI companies in the market today. Its business continues to execute well. Commercial adoption is accelerating. And management has demonstrated that it can grow rapidly while generating meaningful profits.

The recent correction has certainly improved the investment case. But "more attractive" doesn't necessarily mean "cheap." For long-term investors, the real question isn't whether Palantir can grow. It's whether the company can grow fast enough to justify the premium investors are still willing to pay.

If you believe it can, then buying the stock today makes sense. If not, it's best to stay on the sidelines.
2026-07-21 18:43 19d ago
2026-07-21 12:05 19d ago
Memory Stocks Spark a Market Rebound; Dow Jones Joins the Party
MU Micron Technology
FMP Stock News
Original source text
If Monday was a tale of divergence, Tuesday brought something rarer: agreement. All three major indexes climbed together, powered by a semiconductor rally that showed no signs of fading.

By 11:31 a.m. ET, the Nasdaq Composite (^IXIC +1.37%) had jumped 1.3%, the S&P 500 (^GSPC +0.85%) was up 0.7%, and the Dow Jones Industrial Average (^DJI +0.69%) had gained 0.6%. The session started with a brief wobble; all three indexes opened in the green but dipped in the first 20 minutes before finding their footing. By late morning, each had hit fresh session highs.

^IXIC data by YCharts

Why chip stocks keep bouncing back Memory chip stocks stole the show on Tuesday. Micron Technology (MU +12.42%) surged 10.1% after Morgan Stanley predicted memory prices could rise 25% on continued AI demand. SK Hynix (SKHY +13.10%), the Korean memory giant that just debuted on the Nasdaq earlier this month, jumped 10.9% as bargain hunters piled in to take advantage of last week's sell-off.

The iShares Semiconductor ETF (SOXX +5.52%) climbed 5.2%, extending Monday's gains. Memory chips led the charge, but the chipmaker rally was broad. Nvidia (NVDA +1.72%) rose 1.5% after releasing new details about its Vera CPU for AI data centers. Advanced Micro Devices (AMD +7.85%) popped 6.1% without much news of its own. If anything, Nvidia's Vera chips pose a new threat to AMD's EPYC server processors; no one said the stock market had to make sense.

Image source: Getty Images.

The Dow got help from an unlikely source. Caterpillar, Monday's biggest drag, reversed course with a 2.7% gain. 3M (MMM +7.12%) extended a post-earnings rally to 9.8% after beating expectations with bullish second-half guidance. Together, the two industrials contributed more than 230 points to the Dow's advance.

President Donald Trump's announcement of 50% tariffs on most Canadian goods barely registered with investors. The duties take effect in 30 days, leaving room for negotiation. Canadian Prime Minister Mark Carney said Ottawa is ready to talk.

Oil prices kept climbing. Brent crude topped $91 per barrel as tankers reportedly caught fire in the Strait of Hormuz. Gold caught a tailwind, too. The SPDR Gold Shares ETF (GLD +1.90%) rose 1.8%, suggesting some investors are hedging their optimism.

Index

NASDAQ Composite IndexToday's Change

(

1.37

%)

+

349.83

Index Level

25,857.91

The week is just getting started Tuesday's rally suggests investors remain focused on AI-driven semiconductor demand despite mounting geopolitical and trade uncertainties.

So far, 87% of S&P 500 companies have beaten earnings estimates this quarter. The real tests are coming over the next couple of weeks, with several major names on tap before the weekend. Alphabet and Tesla report on Wednesday. Intel, up 7% Tuesday on news of a new foundry customer, reports Thursday. If AI spending remains robust, the chip rally could have room to run.

For now, Tuesday belongs to the memory makers. The semiconductor sector is reminding investors why it remains the market's most volatile corner, and its most closely watched. Whether the current rally has legs depends on what the earnings calls reveal about demand and pricing power in the months ahead.

Anders Bylund has positions in Alphabet, Intel, Micron Technology, and Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Caterpillar, Intel, Micron Technology, Nvidia, Tesla, and iShares Trust-iShares Semiconductor ETF. The Motley Fool recommends 3M. The Motley Fool has a disclosure policy.
2026-07-21 18:43 19d ago
2026-07-21 12:23 19d ago
Will Micron Split Its Stock This Year?
MU Micron Technology
FMP Stock News
Original source text
Shares of Micron Technology (MU +12.42%) have jumped by more than 7x over the past year, driven by phenomenal growth in the company's revenue and earnings.

However, Micron stock has fallen out of favor with investors lately. It has pulled back 29% since hitting a 52-week high on June 25. This sharp drop is unrelated to the company's financial performance, as it continues to benefit from the ongoing memory shortage. Investors, however, have been rotating out of memory stocks lately, which explains the drop in Micron's shares.

As a result, it won't be surprising to see Micron management going for a stock split this year. Let's see why that may be the case.

Image source: Micron Technology.

A stock split could increase demand for Micron stock A stock split is a cosmetic move that increases or decreases the number of outstanding shares of a company while keeping the market capitalization constant. A forward stock split is the most common type of stock split, increasing the outstanding share count and lowering the price per share.

Today's Change

(

12.42

%) $

107.53

Current Price

$

972.99

Now, a forward stock split doesn't alter a company's fundamentals or prospects. However, it is believed that a lower share price could increase demand for a company's shares by making them easier for retail investors to own. Also, a lower share price encourages stronger trading volumes and is considered a sign of management's confidence in a company's prospects.

Given that Micron has delivered stellar returns over the past year and each share of the company now trades at just over $900, as of this writing, the time seems ripe for a forward stock split. Let's say Micron executes a 10-for-1 forward stock split, each share of the company will trade at around $90, potentially boosting demand for its shares.

This could help arrest the recent slide in Micron stock. However, if someone has enough disposable cash to buy this company's shares or access to a brokerage that allows buying fractional shares, buying Micron is a no-brainer following its recent pullback.

The stock's drop is a terrific buying opportunity Micron now trades at just 19 times earnings following its recent slide. Moreover, its forward earnings multiple of just 5.5 is even more attractive. For a company whose earnings increased by a stunning 13x year over year in the previous quarter, buying this stock is a no-brainer at its current multiples.

More importantly, the artificial intelligence (AI)-fueled memory shortage won't end soon. Memory chip demand could outpace supply well beyond 2030, according to industry bellwether SK Hynix. Additionally, Micron is strengthening its long-term revenue pipeline by inking long-term supply agreements with customers.

It recently signed such agreements with companies like Qualcomm and Harman to supply memory chips for automotive applications. Micron notes that it signed 16 long-term customer agreements just last month, which isn't surprising as memory is one of the most important components in data centers, smartphones, personal computers, and automotive applications.

This explains why Micron's terrific earnings growth is poised to continue beyond this year.

Data by YCharts

So, Micron may not trade at a dirt cheap valuation for long. Moreover, a potential stock split could give the stock a psychological boost. That's why investors who can buy Micron stock now should do so right away, as the outstanding growth in its revenue and earnings could send it on a bull run once again.
2026-07-21 18:43 19d ago
2026-07-21 13:20 19d ago
Why Micron Stock Is Still Going Up
MU Micron Technology
FMP Stock News
Original source text
Micron (MU +12.42%) stock shot higher for a second straight day Tuesday, soaring 13.4% through 1 p.m. ET.

You can thank Taiwan Semiconductor Manufacturing Company (TSM +5.39%) for that -- and Bank of America, too.

Image source: Micron.

TSMC raises prices Nikkei Asia reports TSMC will raise prices for contract chip manufacturing by "up to 10%" in 2027 (and some prices might spike 20%). Nikkei says TSMC is doing this to offset "rising costs for materials, manufacturing equipment and construction of new overseas chip plants."

But that's just one reason -- the other reason is that TSMC can raise prices.

Just because input prices rise doesn't mean a manufacturer can raise its product prices without losing customers. If customers balk, the manufacturer may need to absorb the higher costs of the more expensive inputs, hurting its profit margin. In light of strong demand for artificial intelligence chips, though, it seems TSMC is comfortable raising prices -- and confident its customers will not flee.

Today's Change

(

12.42

%) $

107.53

Current Price

$

972.99

Implications for Micron By implication -- because AI chips require lots of memory chips when performing inference functions -- this means Micron can raise its prices, too. So in essence, TSMC has reinforced the bull thesis for Micron stock today.

Separately, Bank of America analyst Vivek Arya addressed concerns that cheap AI models from China might threaten Micron's business... a theory he says is nonsense. Just because Chinese models charge lower prices than American models from Anthropic and OpenAI doesn't mean they're doing so profitably, or that their input costs are lower.

To the contrary, Arya thinks that by using fewer and lower-quality GPUs, Chinese AI companies may actually need to buy more memory chips to answer questions -- not fewer. And if he's right about that, he's just given investors yet another reason to buy Micron stock.

Bank of America is an advertising partner of Motley Fool Money. Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Micron Technology and Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy.
2026-07-21 18:43 19d ago
2026-07-21 13:58 19d ago
Your PC Memory Costs 400% More. Samsung, SK Hynix and Micron Chose AI Instead
MU Micron Technology
FMP Stock News
Original source text
A year ago, a mainstream PC memory kit cost about $75. Today, the same kit can sell for as much as $460. The easy explanation would be another chip shortage. But this time, the culprit isn’t a lack of factories or broken supply chains. It’s a business decision.

The result? AI customers get priority, while everyone else pays more.

AI Is Paying More—So It Gets The WafersSamsung, SK Hynix and Micron control the vast majority of the global DRAM market, giving the three companies enormous influence over where memory production goes.

Unlike conventional DRAM, HBM commands significantly higher prices while consuming much more manufacturing capacity. Every wafer redirected toward AI memory means less supply for PCs, smartphones and automotive chips.

As semiconductor commentator Shanaka Fernando recently argued in a post on X, no coordinated action is needed to create today’s tight memory market. The economics are doing the work. AI memory generates higher returns, and manufacturers are simply following the margins.

The numbers show just how dramatic that shift has become.

According to TrendForce data, conventional DRAM contract prices surged 93% to 98% in the first quarter before climbing another 58% to 63% in the second quarter. NAND flash prices also rose 70% to 75% as suppliers continued prioritizing AI-related products over mainstream memory.

Even the Biggest Customers Are Feeling the PressureThe squeeze is now rippling across the technology industry.

Meanwhile, HBM capacity is effectively sold out through 2026, with much of 2027 production already committed. That has allowed memory makers to lock in premium pricing while demand continues to outstrip supply.

For Samsung, SK Hynix and Micron, the strategy has translated into expanding margins. By selling more high-value AI memory and less conventional DRAM, the industry’s biggest players are earning more from fewer consumer-focused chips.

Today’s Shortage Could Become Tomorrow’s GlutThe current pricing boom is unlikely to last forever.

Micron is building new fabs in Idaho and New York, while Samsung and SK Hynix continue expanding production capacity. Those investments are expected to come online over the next two years, increasing supply just as China’s CXMT rapidly expands its presence in the commodity DRAM market.

For now, however, AI remains first in line.

The bigger story isn’t simply that PC memory has become dramatically more expensive. It’s that AI has fundamentally changed how the world’s three largest memory makers allocate capital. As long as AI data centers continue delivering the highest returns, consumer electronics will keep competing for whatever capacity is left behind.

Photo: Pete Hansen / Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.
2026-07-21 18:43 19d ago
2026-07-21 14:19 19d ago
Micron's AI Boom Is Priced In; Its Profitability Transformation Is Not
MU Micron Technology
FMP Stock News
Original source text
HomeStock IdeasLong IdeasTech 

SummaryMicron Technology, Inc. is re-rated as a Buy, driven by AI super-cycle demand and transformative strategic customer agreements (SCAs).MU’s Q3 ’26 revenue surged 346% YoY, with strong margin expansion—operating margin reached 81.2% and is forecasted to peak at 86% in Q4.SCAs now represent ~20% of DRAM and 1/3 of NAND volume, providing multi-year revenue visibility, margin floors, and $22B in financial commitments.Investors are mispricing MU’s profitability; sustainable margins above 60% are likely, supported by tight supply, pricing power, and structural industry change. JHVEPhoto/iStock Editorial via Getty Images

Investment Thesis Since my last coverage, Micron Technology, Inc.’s (MU) stock has been up by over 100%, and since my initial Buy analysis, it is up almost 300%.

To remind readers, in my initial analysis

1.58K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in MU:CA, MU over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-07-21 18:43 19d ago
2026-07-21 12:41 19d ago
AMC Q2 Earnings & Revenues Beat on Attendance Growth, Stock Up
AMC AMC Entertainment Holdings
FMP Stock News
Original source text
Key Takeaways AMC's Q2 adjusted EPS reached 14 cents, while revenues rose 14.2% YoY to $1.60B.Worldwide attendance climbed 13.5% to 71.3 million, boosting admissions and food and beverage revenues.AMC's adjusted EBITDA jumped 69.6% to a record $321.4 million as margin expanded to 20.1%. AMC Entertainment Holdings, Inc. (AMC - Free Report) reported second-quarter 2026 results, with earnings and revenues beating the Zacks Consensus Estimate. The top and bottom lines improved from the prior-year quarter’s levels.

AMC’s performance benefited from a strong and diverse film slate, which drove higher attendance across its global theater circuit. The company also gained from stronger food, beverage and merchandise sales, increased premium-format usage, solid loyalty and subscription engagement, improved per-patron profitability, portfolio optimization and disciplined cost control.

However, AMC reported a wider GAAP net loss, reflecting substantial interest expense and other non-operating charges related to debt and derivative accounting. The company also remains highly leveraged, and management acknowledged that further debt reduction is necessary

Following the release, AMC stock gained 26.8% during trading hours yesterday.

AMC's Q2 Earnings & Revenue DiscussionFor the second quarter, the company reported adjusted earnings of 14 cents per share compared with breakeven earnings a year ago. The figure surpassed the Zacks Consensus Estimate of 1 cent by 1,300%.

Revenues rose 14.2% year over year to $1.60 billion and beat the consensus mark of $1.51 billion by 5.83%. Higher attendance, increased food and beverage sales, and disciplined cost management drove the performance.

Attendance Gains Support Revenue GrowthWorldwide attendance increased 13.5% year over year to 71.3 million patrons. U.S. attendance rose 12% to 52.5 million, while international attendance advanced 17.9% to 18.8 million.

Admissions revenues climbed 13.2% to $863.1 million. Food and beverage revenues increased 15.3% to $576.1 million, while other theater revenues rose 16.1% to $157.5 million. The gains reflected a stronger film slate and increased spending across AMC’s global theater circuit.

AMC Posts Broad Segment GainsU.S. market revenues increased 13% year over year to $1.26 billion. Adjusted EBITDA for the segment climbed 57.5% to $285.6 million from $181.3 million.

International market revenues advanced 19.2% to $338.1 million. Adjusted EBITDA jumped 336.6% to $35.8 million from $8.2 million. European currency appreciation provided an approximately 2% benefit to international revenues and EBITDA during the quarter.

AMC Improves Per-Patron MetricsConsolidated food and beverage revenues per patron increased to $8.08 from $7.95 in the prior-year quarter. The metric reached $8.95 in the United States and $5.66 in international markets.

Consolidated contribution margin per patron improved to $14.71 from $14.48. U.S. contribution margin per patron rose to $15.55 from $15.27, while the international figure increased to $12.36 from $12.18.

Profitability of AMCConsolidated adjusted EBITDA increased 69.6% year over year to a record $321.4 million from $189.5 million. Adjusted EBITDA margin expanded to 20.1% from 13.6%.

Operating income increased to $238.1 million from $92.6 million. Total operating costs and expenses rose 4.1% to $1.36 billion, well below the pace of revenue growth.

AMC’s Cash Flow & Liquidity StrengthenNet cash provided by operating activities increased 70.1% to $235.4 million. Free cash flow rose to $190.1 million from $88.9 million, while capital expenditures declined to $45.3 million from $49.5 million.

AMC ended the quarter with cash and cash equivalents of $778.4 million, excluding $41.1 million of restricted cash, up 81.7% from $428.5 million as of Dec. 31, 2025. Corporate borrowings declined to $3.85 billion from $4.04 billion at the end of 2025.

AMC’s Zacks Rank & Other Key PicksCurrently, AMC flaunts a Zacks Rank #1 (Strong Buy).

Some other top-ranked stocks from the Consumer Discretionary sector:

Flexsteel Industries, Inc. (FLXS - Free Report) currently flaunts a Zacks Rank #1. You can see the complete list of today’s Zacks Rank #1 stocks here.

The company delivered a trailing four-quarter earnings surprise of 59%, on average. FLXS stock has surged 85.1% in the year-to-date period. The Zacks Consensus Estimate for Flexsteel’s fiscal 2026 sales and EPS implies growth of 3.8% and 14.6%, respectively, from the year-ago levels.

The Marcus Corporation (MCS - Free Report) currently sports a Zacks Rank #1. The company delivered a trailing four-quarter negative earnings surprise of 40.4%, on average. MCS stock has jumped 53.3% in the year-to-date period.

The Zacks Consensus Estimate for Marcus’ 2026 sales and EPS indicates an increase of 6.2% and 211.8%, respectively, from the year-ago levels.

Vince Holding Corp. (VNCE - Free Report) currently has a Zacks Rank of 2 (Buy). The company delivered a trailing four-quarter earnings surprise of 635.7%, on average. VNCE stock has rallied 58.4% in the year-to-date period.

The Zacks Consensus Estimate for Vince Holding’s 2026 sales and EPS implies growth of 7.2% and 34.1%, respectively, from the year-ago levels.
2026-07-21 18:43 19d ago
2026-07-21 13:25 19d ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zillow, Inc. of Class Action Lawsuit and Upcoming Deadlines – Z
Z Zillow
FMP Stock News
Original source text
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Zillow, Inc. (“Zillow” or the “Company”) (NASDAQ: Z). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

The class action concerns whether Zillow and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

You have until August 10, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Zillow securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.   

[Click here for information about joining the class action]  

On September 30, 2025, the U.S. Federal Trade Commission (“FTC”) filed a complaint (the “FTC Complaint”) against Zillow and Redfin alleging violations of federal antitrust laws arising from, among other things, the Redfin Agreement.  The FTC Complaint alleged that “on February 6, 2025, Zillow and Redfin executed an unlawful agreement to remove competition from [the online rental marketplaces industry], starting with a $100 million payment to Redfin to exit the [Internet Listing Services] market.” 

On this news, Zillow’s Class C common stock price fell $3.49 per share, or 4.33%, to close at $77.05 on September 30, 2025.  The following day, it fell a further $3.57 per share, or 4.63%, to close at $73.48 per share on October 1, 2025.  Meanwhile, Zillow’s Class A common stock price fell Class A common stock fell $3.51 per share, or 4.5%, to close at $74.44 per share on September 30, 2025.  The following day, it fell a further $3.26 per share, or 4.37%, to close at $71.18 per share.

Then, on February 10, 2026, Zillow conducted an earnings call to discuss its financial performance for the fourth quarter of 2025.  During the call, Chief Financial Officer Jeremy Hoffman disclosed that the Company was facing significant “ongoing elevated legal expenses.”

On this news, Zillow Class C stock fell $9.32 per share, or 17.12%, to close at $45.10 per share on February 11, 2026.  The next day, it fell a further $1.40 per share, or 3.1%, to close at $43.70 per share on February 12, 2026.  Meanwhile, Zillow Class A stock fell $9.05 per share, or 16.5%, to close at $45.66 on February 11, 2026.  The following day, it fell a further $1.84, or 4.02%, to close at $43.82 per share on February 12, 2026.

Finally, on May 7, 2026, Reuters published an article entitled “Zillow, Redfin fail to end FTC lawsuit claiming they suppressed rental competition.”  The article reported that a “federal judge rejected [Zillow and Redfin’s] request to end a [FTC] lawsuit accusing them of illegally agreeing to suppress competition for online apartment rental listings.”

On this news, Zillow’s Class C common stock fell $0.85 per share, or 1.9%, to close at $43.68 on May 7, 2026.  The following day, Zillow’s Class C common stock fell a further $2.25 per share, or 5.15%, to close at $41.43 on May 8, 2026.  Meanwhile, Zillow’s Class A stock fell $0.79 per share, or 1.76%, to close at $44.04 on May 7, 2026.  The following day, it fell a further $2.10 per share, or 4.76%, to close at $41.94 on May 8, 2026.  The following trading day, May 11, 2026, Zillow Class A common stock fell a further $1.29, or 3.07%, to close at $40.65 per share.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. 

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT: 
Danielle Peyton 
Pomerantz LLP 
[email protected] 
646-581-9980 ext. 7980 
2026-07-21 18:42 19d ago
2026-07-21 13:03 19d ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
REGN Regeneron Pharmaceuticals
FMP Stock News
Original source text
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

The class action concerns whether Regeneron and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

You have until September 14, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Regeneron securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.   

[Click here for information about joining the class action]

On April 29, 2026, during during Regeneron’s first quarter earnings call, the Company disclosed that the Phase III Fianlimab-Libtayo Study had been altered, expanding the number of patients in the study eligible for “analysis of progression-free survival.” 

On this news, Regeneron’s stock price fell $45.41 per share, or 6.21%, to close at $686.36 per share on April 29, 2026.  

Then, on May 15, 2026, Regeneron issued a press release disclosing that the “Phase 3 Trial of Fianlimab . . . did not reach statistical significance for the primary endpoint of improvement in progression-free survival (PFS).” 

On this news, Regeneron’s stock price fell $68.57 per share, or 9.82%, to close at $629.68 per share on May 16, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. 

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: 
Danielle Peyton 
Pomerantz LLP 
[email protected] 
646-581-9980 ext. 7980   
2026-07-21 18:42 19d ago
2026-07-21 12:23 19d ago
TSMC Is Set to Ratchet AI Costs Even Higher. What It Means for Intel.
TSM Taiwan Semiconductor
FMP Stock News
Original source text
TSMC could be about to pile even more pain on Big Tech companies, which are already stretching their finances to invest in AI.
2026-07-21 18:42 19d ago
2026-07-21 12:31 19d ago
AI Demand Leads to Blowout Results for These Semiconductor Giants
TSM Taiwan Semiconductor
FMP Stock News
Original source text
Key Takeaways Both ASML and TSM recently posted rock-solid quarterly results, with each raising sales outlooks. AI-driven demand remains red hot, with both companies playing critical roles in the landscape. Bullish revisions have flowed in post-earnings, keeping their near-term outlooks bullish. The 2026 Q2 earnings season really picks up pace this week, with a few Magnificent Seven members, namely Alphabet and Tesla, headlining the docket. The big banks got us off to a great start, delivering solid results without giving the market any unexpected spooks.

So far throughout the cycle, several companies, including Taiwan Semiconductor (TSM - Free Report) and ASML Holding (ASML - Free Report) , have both raised sales guidance, again underpinning just how fierce the demand picture has become concerning the AI frenzy.

ASML Plans to Increase CapacityASML designs, develops, integrates, and services advanced systems used by major global semiconductor manufacturers to create cutting-edge chips that power artificial intelligence, high-performance computing, and a wide array of other electronic and communications technologies.

Strong AI-driven demand led ASML to raise its full-year sales outlook in its recent quarterly release, also now planning to boost its machine production capacity over the next several years due to strong order intake. Overall sales of $10.8 billion grew 25% YoY, while earnings also saw strong growth, both crushing our consensus estimates.

The stock’s outlook remains bullish, with EPS revisions jumping higher across the board post-earnings.

Image Source: Zacks Investment Research

TSM Posts Huge Growth Taiwan Semiconductor, a current Zacks Rank #1 (Strong Buy), is the world's leading semiconductor foundry, reflecting a highly critical player in the technology landscape amid the AI frenzy. It manufactures the powerful chips needed to run next-generation AI technologies.

Thanks to the huge wave of artificial intelligence spending, TSMC raised its full-year revenue growth forecast to roughly 40%. The company also increased its CapEx budget to a range of $60 - $64 billion to expand its manufacturing capacity to keep pace with the soaring demand for advanced AI chips. Sales of $40.2 billion grew 33% YoY, with earnings also climbing a rock-solid 75% YoY. Both items beat our consensus estimates handily.

EPS revisions have moved higher across near-term timeframes following the release, keeping the stock’s momentum and overall outlook notably bright.

Image Source: Zacks Investment Research

Bottom Line

The 2026 Q2 earnings season is kicking into a much higher gear this week, with many notable companies slated to report in the coming days and weeks.

And so far, both ASML Holding (ASML - Free Report) and Taiwan Semiconductor (TSM - Free Report) have been standouts thanks to red-hot demand. The results from the pair further underscore just how fierce the AI landscape remains, with each posting blockbuster numbers while also raising their sales outlooks.  
2026-07-21 18:42 19d ago
2026-07-21 13:32 19d ago
IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?
LLY Eli Lilly & Co
FMP Stock News
Original source text
Investors choosing between the iShares Global Healthcare ETF (IXJ +0.38%) and the Invesco S&P 500 Equal Weight Health Care ETF (RSPH 0.07%) need to weigh the stability of cap-weighted global giants against an equal-weighted, U.S.-only strategy.

While both funds target the same sector, they take very different approaches. RSPH’s equal-weight strategy means every one of its holdings has a roughly equal allocation in its portfolio. IXJ, by contrast, casts a wider net globally and uses traditional market-cap weighting, which favors the largest pharmaceutical companies.

Snapshot (cost & size)MetricRSPHIXJIssuerInvescoiSharesExpense ratio0.40%0.40%1-year return (as of July 20, 2026)21.01%18.29%Dividend yield0.70%1.47%Beta0.810.52AUM$704.8 million$3.8 billionBeta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-year return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.

The two funds' expense ratios are identical at 0.4%. However, IXJ offers a notably higher dividend for income-seeking investors, with a yield more than double RSPH’s.

Performance & risk comparisonMetricRSPHIXJMax drawdown (5 yr)(21.95%)(18.14%)Growth of $1,000 over 5 years (total return)$1,167$1,251RSPH carries a more aggressive risk profile, with a higher beta and a deeper five-year maximum drawdown than IXJ. That's consistent with its structure -- by giving equal weight to smaller, faster-growing healthcare names, the fund becomes more sensitive to swings in those stocks, for better or worse.

What's insideLaunched in 2001, IXJ provides exposure to a diversified basket of global healthcare equities spanning pharmaceuticals, biotech, and medical devices. The fund holds 110 securities, and its cap-weighted approach results in meaningful concentration at the top. Its largest positions include Eli Lilly and Co. (LLY +1.48%) at 10.9%, Johnson & Johnson (JNJ +0.21%) at 7.0%, and Abbvie (ABBV +0.80%) at 5.1%.

RSPH tracks an index that assigns identical weight to every healthcare company in the S&P 500, reducing the influence of mega-cap giants and increasing the fund's sensitivity to smaller, high-growth names. It holds 60 securities, with top positions in Moderna (MRNA +0.44%) at 2.5%, Bio-Techne Corp. (TECH +0.22%) at 2.2%, and Charles River Laboratories International (CRL 0.56%) at 2.0%. Those weights aren't perfectly even because the index only resets to equal weight at each quarterly rebalance -- stocks that outperform their peers drift to a slightly higher weight, and laggards drift lower, until the next reset. RSPH was launched in 2006.

For more guidance on ETF investing, check out the full guide at this link.

What this means for investorsAs with most ETF comparisons, the best choice here really comes down to what role you want a healthcare ETF to play in your portfolio. IXJ behaves more like a defensive, income-generating fund. Its cap-weighted structure concentrates money in established drugmakers like Eli Lilly, Johnson & Johnson, and AbbVie -- companies with steady cash flows, established products, and a long history of paying dividends. That's fairly typical of global healthcare funds, which tend to gravitate toward the biggest, most stable names by design.

RSPH takes a different tack. By weighting every S&P 500 healthcare stock equally, it hands more influence to smaller, faster-growing companies like Moderna and Bio-Techne -- names with more room to run, but also more room to fall, as reflected in the fund's higher beta and deeper five-year maximum drawdown.

Neither of these approaches is inherently better. These ETFs were simply built for different goals. Retirees or conservative investors leaning on dividend income may find IXJ's steadier, higher-dividend profile more appealing. Investors willing to stomach more volatility in exchange for greater potential upside from smaller, growth-oriented healthcare names may prefer RSPH.
2026-07-21 18:42 19d ago
2026-07-21 12:20 19d ago
Danaher Q2 Earnings Review: Nothing Exciting For Me To Buy This Dip
DHR Danaher
FMP Stock News
Original source text
4.64K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-07-21 18:42 19d ago
2026-07-21 12:36 19d ago
Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
DHR Danaher
FMP Stock News
Original source text
Key Takeaways Danaher beat Q2 earnings and revenue estimates as sales rose 5.5% year over year.DHR's Life Sciences delivered its strongest quarter in years, while core sales rose 3.0%.Danaher raised its 2026 adjusted EPS outlook and expects 3-4% adjusted core sales growth. Danaher Corporation’s (DHR - Free Report) second-quarter 2026 adjusted earnings of $1.94 per share beat the Zacks Consensus Estimate of $1.84. The bottom line increased 7.8% year over year.

Revenues of $6.3 billion surpassed the consensus estimate of $6.09 billion and rose 5.5% year over year. Core sales advanced 3.0%, while core sales excluding respiratory testing increased 4.5%. Acquisitions added 1.5% to reported sales growth, while foreign-currency translation contributed 1.0%. Life Sciences segment delivered its strongest quarter in several years.

DHR’s Segmental DiscussionRevenues from the Life Sciences segment totaled $1.88 billion, up 5.5% year over year. Core sales increased 5.5% year over year. Foreign-currency translations had no impact on sales. Operating profit was $244 million against a loss of $239 million reported in the year-ago quarter.

Revenues from the Diagnostics segment totaled $2.47 billion, up 7.0% year over year. Core sales increased 2.0%, acquisitions contributed 4.0% while foreign currency had a positive impact of 1.0% on sales. Operating profit was $416 million, down 24.9% on a year-over-year basis.

Revenues from the Biotechnology segment totaled $1.92 billion, up 4.0% year over year. Core sales increased 2.5% year over year and foreign-currency translations had a positive impact of 1.5%. Operating profit was $556 million, up 4.7% year over year.

Danaher’s Margin ProfileIn the second quarter, Danaher’s cost of sales increased 10% year over year to $2.65 billion. Gross profit of $3.61 billion increased 2.5% year over year. The gross margin was 57.6% compared with 59.3% in the year-ago quarter.

Selling, general and administrative expenses decreased 12.2% year over year to $2.07 billion. Research and development expenses were $412 million, up 2.2% year over year.

Danaher’s operating profit increased 48.3% year over year to $1.13 billion. Operating margin increased to 18.0% from 12.8% in the year-ago quarter.

DHR’s Balance Sheet & Cash FlowExiting the second quarter, DHR had cash and equivalents of $4.35 billion compared with $4.62 billion at 2025-end. Long-term debt was $25.1 billion at the end of the quarter compared with $18.4 billion at the end of December 2025.

Danaher generated net cash of $2.85 billion from operating activities in the first six months of 2026 compared with $2.64 billion in the previous year’s comparable period. Capital expenditures totaled $506 million in the same period, up 2.6% year over year. Adjusted free cash flow increased 15.5% year over year to $1.27 billion in the first six months of 2026.

In the same period, DHR paid out dividends of $509 million, up 20.3% on a year-over-year basis.

Danaher Raises 2026 EPS ViewFor the third quarter of 2026, Danaher expects adjusted core sales to increase 2-3% on a year-over-year basis.

The metric is anticipated to increase 3-4% on a year-over-year basis in 2026. The company expects adjusted earnings to be $8.45-$8.60 per share compared with $8.35-$8.55 expected earlier.

DHR’s Zacks RankThe company currently carries a Zacks Rank #2 (Buy).

Other Stocks to ConsiderSome other top-ranked companies from the same space are discussed below:

Progyny, Inc. (PGNY - Free Report) currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

PGNY delivered a trailing four-quarter average earnings surprise of 16.1%. In the past 30 days, the Zacks Consensus Estimate for Progyny’s 2026 earnings has increased 3.6%.

Avantor, Inc. (AVTR - Free Report) currently carries a Zacks Rank #2 (Buy). AVTR delivered a trailing four-quarter average earnings surprise of 0.7%.

In the past 30 days, the Zacks Consensus Estimate for Avantor’s 2026 earnings has remained steady.

CVS Health Corporation (CVS - Free Report) currently carries a Zacks Rank of 2. CVS delivered a trailing four-quarter average earnings surprise of 16.8%.

In the past 30 days, the Zacks Consensus Estimate for CVS Health’s 2026 earnings has increased 0.7%.
2026-07-21 18:42 19d ago
2026-07-21 12:38 19d ago
Recce Pharmaceuticals advances dual Phase 3 programs and MENA licensing strategy in strong June quarter
TXN Texas Instruments
FMP Stock News
Original source text
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) advanced its diabetic foot infection treatment toward commercialisation during the June quarter, securing approval to expand an Australian study into a pivotal Phase 3 trial while progressing a proposed 10-year licensing agreement across the Middle East and North Africa.

The synthetic anti-infective developer also completed a successful regulatory inspection of its Indonesian Phase 3 trial site, raised A$4 million through an institutional placement and reported a pro-forma cash position of about A$33.1 million.

MENA licensing opportunity Recce signed a non-binding term sheet with a publicly listed Middle Eastern pharmaceutical company that has a multi-billion-dollar market capitalisation and a distribution network spanning more than 30 international markets.

The proposed agreement would grant the partner exclusive rights to register, market and distribute RECCE® 327 Topical Gel, or R327G, for diabetic foot infections across Saudi Arabia, the Gulf Cooperation Council countries, Egypt, Algeria and Morocco.

Under the proposed commercial terms, Recce could receive an upfront fee and milestone payments totalling up to US$3.5 million, equivalent to around A$5 million.

It would also receive 30% of the net selling price, plus an additional 6% royalty on annual net sales above US$50 million. The proposed treatment price is US$1,500, subject to agreement with Saudi Arabia’s regulator.

The parties are targeting completion of a definitive agreement during the December 2026 quarter, subject to due diligence, negotiations and customary approvals.

Australian study elevated to Phase 3 The Human Research Ethics Committee approved a protocol amendment that advances Recce’s Australian R327G diabetic foot infection study from Phase 2 into a pivotal Phase 3 clinical trial.

The revised study can enrol up to 200 patients and has so far treated 18 participants. Interim analysis is planned after half the enrolled patients complete treatment, with full recruitment expected by the end of 2027.

Eligibility has been broadened to include moderate as well as mild diabetic foot infections, expanding the available patient population. The study will be conducted to Australian Therapeutic Goods Administration and US Food and Drug Administration standards.

Indonesian trial passes inspection Indonesia’s National Agency of Drug and Food Control completed a comprehensive inspection of a Phase 3 clinical trial site without identifying any findings that would prevent the study from continuing.

The review examined trial conduct, site processes, data integrity and compliance with Good Clinical Practice requirements.

Patient dosing remains underway, with an interim data readout expected after 155 of the planned 310 patients have been enrolled. Recce anticipates potential Indonesian regulatory approval during calendar 2026.

Funding clinical and commercial milestones Recce raised A$4 million before costs through the issue of 10 million shares at A$0.40 each and subsequently launched a share purchase plan targeting up to a further A$4 million.

The company also received an A$3.67 million tax refund after quarter-end, primarily comprising its FY2025 research and development tax incentive.

Recce ended the quarter with A$2.9 million in cash before the expected rebate and recorded net operating cash outflows of A$2.2 million, including A$1.6 million directed toward research and development.

Its pro-forma cash position of about A$33.1 million includes capital-raising proceeds and the potential drawdown of available debt funding, subject to conditions. 
2026-07-21 18:42 19d ago
2026-07-21 13:00 19d ago
Terrain Minerals advances Lightning gold resource as June quarter delivers high-grade drilling and broader discovery pipeline
TXN Texas Instruments
FMP Stock News
Original source text
Terrain Minerals Ltd (ASX:TMX, OTC:TMXAF, FRA:T4Y) advanced its flagship Smokebush Gold and Silver Project toward a maiden mineral resource estimate during the June 2026 quarter, supported by high-grade drilling results, completed technical studies and new exploration targets across its Western Australian portfolio.

At the Lightning prospect, Terrain completed 29 reverse circulation holes for 5,309 metres, testing extensions to the known gold system along strike and at depth.

Standout intersections included 8 metres at 6.87 g/t gold from 76 metres, including 5 metres at 10.06 g/t, and 7 metres at 7.08 g/t from 217 metres, including 1 metre at 21.80 g/t.

Other results included 5 metres at 3.26 g/t gold from 196 metres and 11 metres at 2.61 g/t from 86 metres.

The drilling confirmed continuity across the Lightning and Monza structures and indicated the possible emergence of a third mineralised zone, providing further targets for follow-up drilling. 

Lightning resource work nears completion Terrain also completed four diamond holes for 671 metres, comprising 340 metres of RC pre-collars and 331 metres of diamond tails.

The program delivered density measurements and structural data required for the planned maiden “starter” mineral resource estimate at Lightning.

Diamond drilling returned a high-grade intercept of 3.4 metres at 4.96 g/t gold from 213.6 metres, including 1 metre at 10.93 g/t, supporting the continuity of mineralisation at depth.

Metallurgical test work commenced during the quarter, with early geological assessment indicating the gold is unlikely to be refractory and may be suited to a conventional processing route.

Terrain also completed flora and fauna surveys, a differential GPS survey and topographic drone work, while submitting an application for a roughly seven-kilometre haul road connecting the mining lease with the Warriedar Coppermine Road.

The company said mining studies would begin alongside continued exploration following completion of the initial resource estimate.

Wildflower drilling supports emerging gold camp First-pass drilling at the nearby Wildflower area intersected gold across the Wildflower, T16 and Cota targets.

Terrain drilled 13 RC holes for 2,276 metres, with gold recorded in eight holes.

Key results included 1 metre at 6.05 g/t gold from 171 metres at Wildflower and 1 metre at 4.38 g/t gold with 20.34 g/t silver from 140 metres at Cota.

The strongest intersections were generally encountered below 130 metres, mirroring the depth profile observed at Lightning.

Terrain said the results supported its induced polarisation targeting strategy and strengthened the potential for multiple deposits associated with the Mt Mulgine intrusive system.

The company also expanded an IP survey over the granted Lightning mining lease to test the Hurley, Paradise City and T17 prospects for repetitions of Lightning-style mineralisation.

Rare earth and gold targets broaden portfolio Subsequent to quarter-end, Terrain reported results from a 35-hole aircore campaign at the Lort River Rare Earth Elements Project near Esperance.

Rare earth mineralisation was identified in 25 holes, led by 8 metres at 3,349 ppm total rare earth oxides from 27 metres, including 6 metres at 4,230 ppm and a peak three-metre composite of 5,568 ppm.

The higher-grade zone contained a strong heavy rare earth component, including dysprosium and terbium, while several holes ended in mineralisation.

Terrain is progressing single-metre assays and evaluating deeper reverse circulation drilling to support future resource definition.

At the Carlindie Project near Port Hedland, a first-pass soil program defined a coherent gold-pathfinder anomaly measuring about 4 kilometres by 3 kilometres.

The anomaly coincides with a concealed greenstone target independently identified through machine-learning-assisted bedrock mapping.

Terrain plans field reconnaissance around a high-intensity bismuth-tungsten feature, followed by a CSIRO UltraFine+ soil program from August 2026.

Placement supports exploration programs Terrain completed a A$1.5 million placement during the quarter through the issue of about 375 million shares at A$0.004 each.

Funds have been directed toward the Lightning resource and mining studies, further work at Lort River and Carlindie, and general working capital.

The company finished the quarter with A$1.39 million in cash after spending A$868,000 on exploration and evaluation activities.

About Terrain Minerals Terrain Minerals is an exploration company with projects across Western Australia and Queensland.

Its principal focus is the 100%-owned Smokebush Gold and Silver Project in the Murchison region of Western Australia, where Lightning is the company’s most advanced target and Wildflower provides additional district-scale exploration potential.

Terrain’s wider portfolio includes the Larin’s Lane gallium and rare earth project, the Lort River rare earth project, the Carlindie lithium and gold project and the Biloela gold and copper project in Queensland.
2026-07-21 18:42 19d ago
2026-07-21 12:41 19d ago
SSUMY or HON: Which Is the Better Value Stock Right Now?
HON Honeywell
FMP Stock News
Original source text
Investors interested in Diversified Operations stocks are likely familiar with Sumitomo Corp. (SSUMY) and Honeywell International Inc. (HON). But which of these two stocks presents investors with the better value opportunity right now?
2026-07-21 18:41 19d ago
2026-07-21 12:19 19d ago
Pomerantz Law Firm Announces the Filing of a Class Action Against Intuit Inc. and Certain Officers – INTU
INTU Intuit
FMP Stock News
Original source text
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Intuit Inc. (“Intuit” or the “Company”) (NASDAQ: INTU) and certain officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv-07086, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Intuit securities between August 22, 2025 and May 20, 2026, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are an investor who purchased or otherwise acquired Intuit securities during the Class Period, you have until September 8, 2026, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

[Click here for information about joining the class action]

Intuit provides financial management, payments and capital, compliance, and marketing products and services in the United States. The Company has four reportable business segments: (i) Global Business Solutions; (ii) Consumer; (iii) Credit Karma; and (iv) ProTax.  Intuit’s Consumer segment provides do-it-yourself (“DIY”) and assisted income tax preparation products and services under the “TurboTax” brand name, whereas its ProTax segment provides tax-preparation software products and electronic tax filing, payment, and related products and services.  The Company sells its products and services through direct sales channels, multichannel shop-and-buy experiences, mobile application stores, and partner and other channels.

At all relevant times, Defendants touted purportedly significant “momentum” across Intuit’s various business segments, particularly with respect to its tax-related business.  Defendants attributed this purported “momentum” to, inter alia, Intuit’s purportedly significant competitive advantages, including integration of artificial intelligence (“AI”) in its business and operations.

For example, in August 2025, Defendants provided financial guidance for Intuit’s fiscal full year (“FY”) of 2026, ended July 31, 2026, including 8% revenue growth in its TurboTax business, citing “outstanding execution across our platform” and “breakthrough adoption in assisted tax” as a result of the aforementioned purported competitive advantages.

The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) they had overstated Intuit’s competitive advantages and growth, as well as the overall strength and sustainability of its business model and operations; (ii) in reality, Intuit was losing significant business in its tax-related business, particularly in its TurboTax business, as a result of, inter alia, increasing competitive and pricing pressures; (iii) accordingly, Intuit’s previously issued FY 2026 TurboTax revenue growth guidance was unreliable and/or unrealistic; and (iv) as a result, Defendants’ public statements were materially false and misleading at all relevant times.

The truth began to emerge on May 20, 2026, when, during pre-market hours, Reuters published an article entitled “Intuit to cut 17% of global jobs to streamline operations, memo shows”.  Citing an internal Company memorandum and email from Defendant Sasan K. Goodarzi (“Goodarzi”), Intuit’s Chairman and Chief Executive Officer, to staff earlier in the day, the article reported that “Intuit . . . is laying off about 17% of its workforce, or about 3,000 employees worldwide, to streamline operations and sharpen focus on its key bets including its AI efforts[.]”  The article further revealed that Intuit “is also winding down its Reno and Woodland Hills offices as ⁠part of a strategic restructuring to consolidate teams in key hubs, according to the memo.”

On this news, Intuit’s stock price fell $15.78 per share, or 3.95%, to close at $383.93 per share on May 20, 2026.

The same day, during post-market hours, Intuit issued a press release announcing its fiscal third quarter (“Q3”) 2026 results.  Therein, Defendants reported weak Q3 2026 tax season revenue, including, inter alia, TurboTax revenue that grew by only 7% year-over-year, versus consensus estimates of at least 8% revenue growth.  During the accompanying earnings call held the same day, also during post-market hours, Defendant Sandeep S. Aujla, Intuit’s Executive Vice President and Chief Financial Officer, acknowledged that, with respect to TurboTax, “we did not have the overall tax season we expected[.]”  On the same call, Defendant Goodarzi likewise stated that he was “dissatisfied with our performance”, noting “[w]e faced pressure among the most price-sensitive DIY filers earning less than $50,000 a year”, and that “[w]e lost on price.”  Defendant Goodarzi also revealed that TurboTax online paying units were expected to grow by only 2% as total Internal Revenue Service filers were expected to decline by approximately 30 basis points, representing the “most significant industry-wide contraction since the post-COVID tax season.”  Accordingly, Defendant Goodarzi acknowledged that “we expect TurboTax to grow 7% for the full year”—down from Defendants’ prior guidance of 8% growth—and that, “[t]o reaccelerate this part of our business,” Defendants will need to “evolve our business model by delivering the right lineups and price points to meet simple filers’ needs at the low end and lean into the power of our broader Consumer platform to monetize beyond tax.”

Following these disclosures, Intuit’s stock price fell $76.86 per share, or 20.02%, to close at $307.07 per share on May 21, 2026.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980
2026-07-21 18:41 19d ago
2026-07-21 13:00 19d ago
Intuit Inc. (INTU) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
INTU Intuit
FMP Stock News
Original source text
Intuit Inc. (INTU) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit PR Newswire LOS
2026-07-21 18:41 19d ago
2026-07-21 13:35 19d ago
Lockheed's Martin Says Space Is Now Key to Warfighting Plans
LMT Lockheed Martin
FMP Stock News
Original source text
The UK is hosting the Farnborough International Air Show, a key gathering of leaders in the aerospace industry. Wes Streeting, the new UK Defence Secretary, has set aside billions for space capabilities.
2026-07-21 18:41 19d ago
2026-07-21 14:26 19d ago
VCF is Becoming Broadcom's Growth Engine: More Upside Ahead?
AVGO Broadcom
FMP Stock News
Original source text
Key Takeaways Broadcom's VCF demand helped Infrastructure Software revenue rise 9% to $7.2 billion in fiscal Q2.VCF 9.1 unifies AI inference, Kubernetes and virtualized workloads across NVIDIA, AMD and Intel platforms.Standard Chartered is standardizing on VCF across 54 markets, with nearly 70% of infrastructure migrated. Broadcom’s (AVGO - Free Report) VMware Cloud Foundation (VCF) is becoming a major growth engine for the Infrastructure Software business. Demand for VCF 9.1 remains strong as enterprises increasingly deploy on-premises private clouds to support AI inference, Kubernetes and traditional virtualized workloads on a common platform. This momentum helped Infrastructure Software revenues increase 9% year over year to $7.2 billion in the second quarter of fiscal 2026, with Broadcom projecting an acceleration to approximately $8.9 billion, up 31% year over year, in the third quarter of fiscal 2026.

Broadcom is positioning VCF as the operating platform for enterprise AI. The latest VCF release supports heterogeneous computing across NVIDIA (NVDA - Free Report) , AMD and Intel platforms, allowing enterprises to run AI inference, Kubernetes and traditional virtualized workloads on a unified private cloud. Customers deploying VCF for private cloud modernization are also adopting AI workloads. This enables AVGO to sell additional software capabilities around automation, security, networking and AI infrastructure management. This is increasing customer spending while strengthening long-term annual recurring revenue, which grew 17% year over year in the second quarter of fiscal 2026.

Standard Chartered recently selected VCF to modernize its global IT infrastructure, reinforcing the growing enterprise adoption of Broadcom’s flagship private cloud platform. The bank is standardizing its infrastructure on VCF to support secure, software-defined private cloud operations across 54 markets. With nearly 70% of its infrastructure already migrated, the deployment enables faster infrastructure provisioning, stronger zero-trust security and greater operational resilience for mission-critical banking services.

The Standard Chartered deployment strengthens Broadcom’s long-term software prospects by showcasing VCF’s ability to win large, multi-year enterprise transformation projects in highly regulated industries. As more global enterprises adopt VCF to modernize private cloud environments while preparing AI-ready infrastructure, Broadcom is well positioned to expand recurring software revenues, increase annual recurring revenue and strengthen the Infrastructure Software segment as a durable growth driver, alongside its AI semiconductor business.

AI & VMware to Drive AVGO’s Top-Line GrowthBroadcom expects AI semiconductor revenues to reach approximately $56 billion in fiscal 2026, up roughly 180% year over year, and exceed $100 billion in fiscal 2027. Long-term agreements with Google, Meta, OpenAI and Anthropic provide strong visibility into future demand for custom AI accelerators and networking products.

Broadcom’s AI semiconductor business builds the hardware infrastructure, while VCF provides the software layer enterprises need to deploy and manage AI applications securely. This combination allows AVGO to participate across the AI stack — from silicon and networking to enterprise software — creating multiple avenues for sustained revenue growth and reducing dependence on any single business segment.

AVGO Faces Tough CompetitionBroadcom is facing stiff competition in the semiconductor and infrastructure software markets from NVIDIA and Cisco Systems (CSCO - Free Report) , respectively.

NVIDIA is at the center of AI computing, with its products widely used across data centers, gaming and autonomous vehicles. The company’s newer Hopper 200 and Blackwell GPU platforms are being adopted quickly as customers work to grow their AI infrastructure. Data Center revenues reached $75.2 billion in the first quarter of fiscal 2027, up 92% from a year ago and up 21% sequentially, driven by the ramp-up of Blackwell 300 products and demand for InfiniBand, Spectrum-X Ethernet and NVLink solutions.

Cisco competes with Broadcom in the AI networking infrastructure domain. Cisco provides AI networking systems built around Silicon One, Nexus switches, routers, Acacia optics and end-to-end AI fabrics. Cisco recently raised its fiscal 2026 hyperscaler AI infrastructure orders target to $9 billion (from $5 billion), highlighting strong traction in AI networking. Cisco’s strategy to deliver the entire AI networking stack by combining Silicon One, Nexus switching, Acacia optics, security, observability and AI networking software has been a key catalyst.

AVGO’s Share Price Performance, Valuation & EstimatesBroadcom shares have appreciated 11% year to date, underperforming the broader Zacks Computer and Technology sector’s return of 12.1%.

AVGO Stock Lags Sector
Image Source: Zacks Investment Research

The AVGO stock is trading at a premium, with a forward 12-month price/sales of 11.59X compared with the broader sector’s 6.6X. Broadcom has a Value Score of D.

AVGO Stock’s Valuation
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for fiscal 2026 earnings is pegged at $11.74 per share, up by a penny over the past 30 days, suggesting 72.14% growth from fiscal 2025’s reported figure.
 

Broadcom currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.